QLARIS BIO
Qlaris Bio focuses on developing novel and innovative therapies for serious and debilitating ophthalmic diseases. Qlaris Bio is a spinout company of Qrativ, a biotechnology incubator formed as a joint venture between Mayo Clinic and inference, a pharmaceutical-focused artificial intelligence company. Its lead program is QLS-101, a novel compound invented at Mayo Clinic and the University of Minnesota. QLS-101, with its unique and first-in-class mechanism of action, may potentially serve as an ef... ficacious treatment for high unmet need conditions related to disturbances in intraocular pressure, including a sight-threatening and progressive Pediatric Rare Disease for which effective therapies remain elusive and limited. Qlaris Bio was founded in 2019 and is headquartered in Cambridge, Massachusetts.
QLARIS BIO
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2019-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.qlaris.bio
Total Employee:
1+
Status:
Active
Total Funding:
8.2 M USD
Current Advisors List
Current Employees Featured
Founder
Investors List
Mayo Clinic Ventures
Mayo Clinic Ventures investment in Series A - Qlaris Bio
Correlation Ventures
Correlation Ventures investment in Series A - Qlaris Bio
New Leaf Venture Partners
New Leaf Venture Partners investment in Series A - Qlaris Bio
Official Site Inspections
http://www.qlaris.bio
- Host name: 68.111.223.35.bc.googleusercontent.com
- IP address: 35.223.111.68
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York